Mabura is a biologic therapy based on adalimumab, a fully human monoclonal antibody that targets and neutralizes tumor necrosis factor-alpha (TNF-α). It is used to treat a wide range of autoimmune disorders, including rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, ulcerative colitis, and plaque psoriasis.